Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC) → docetaxel (T) with or without capecitabine (X) in high-risk early breast cancer: Exploratory Ki-67 analyses.
暂无分享,去创建一个
F. Holmes | J. O’Shaughnessy | J. Pippen | J. Blum | S. Vukelja | R. Rivera | S. Sedlacek | D. Paul | K. McIntyre | C. Stokoe | R. Brooks | L. Krekow | D. Lindquist | C. Lopez-Diaz